Structural MRI for the Early Diagnosis of Alzheimer Disease in Patients with MCI - ...
Mar 1, 2021 - There is insufficient evidence to recommend structural brain magnetic resonance imaging to diagnose Alzheimer disease in patients with mild cognitive impairment.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2021/0301/p273.html
Acute Appendicitis: Computed Tomography for Diagnosis in Adults - Cochrane for ...
Oct 1, 2020 - In a nonpregnant adult with clinical signs and symptoms of appendicitis, computed tomography has a sensitivity of 95% and specificity of 94%.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2020/1001/p403.html
General Health Checks in Adults for Reducing Disease-Related Morbidity and Mortality - ...
Dec 1, 2019 - General health check visits have no benefit on cardiovascular morbidity or on total, cardiovascular, or cancer-related mortality. There is also no evidence that they cause patient harm.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2019/1201/p676.html
Noninvasive Diagnostic Tests for Helicobacter pylori Infection - Cochrane for ...
Jul 1, 2019 - When compared with serology or stool antigen tests, the urea breath test has the highest diagnostic accuracy to identify H. pylori infection in patients without a history of gastrectomy or recent use of antibiotics or proton pump inhibitors.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2019/0701/p16.html
Cerebrospinal Fluid Biomarkers for Detection of Alzheimer Disease in Patients with Mild...
Jun 1, 2018 - There is insufficient evidence to support the routine use of cerebrospinal fluid (CSF) biomarkers for the detection of progressive dementias in patients with mild cognitive impairment (MCI). These tests carry the risk of overdiagnosis of dementia and, therefore, overtreatment.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2018/0601/p714.html
Mini-Mental State Examination for the Detection of Dementia in Older Patients - ...
Dec 1, 2016 - When scores are adjusted based on a patient's education level, the MMSE may be useful to rule out a diagnosis of dementia in clinically unevaluated patients 65 years and older (sensitivity = 97%; specificity = 70%). Scores of less than 24 may also be useful to rule in dementia in ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2016/1201/p880.html
The Impact of Personalized Risk Communication on Screening Decisions - Cochrane for ...
Feb 1, 2014 - Patients presented with personalized risk information are more likely to make informed decisions about screening than patients who are presented with generic risk information. Individualizing risk appears to improve the accuracy of patients' risk perception and decrease anxiety.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2014/0201/p175.html
General Health Checks for Reducing Morbidity and Mortality - Cochrane for Clinicians - ...
Oct 1, 2013 - Although general health checks increase the number of new diagnoses, they do not decrease total, cardiovascular-related, or cancer-related morbidity or mortality. The studies in this Cochrane review have limited applicability to the current recommended practice of providing selective, ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2013/1001/p432.html
Interventions to Increase Cervical Cancer Screening Rates - Cochrane for Clinicians - ...
Mar 1, 2012 - Invitation letters are the most studied method of encouraging cervical cancer screening, and they are effective (relative risk [RR] = 1.44; 95% confidence interval [CI], 1.24 to 1.52).1–3 Invitation letters may be more cost-effective than more intensive recruitment efforts (e.g., ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2012/0301/p443.html
Preoperative Testing for Patients Undergoing Cataract Surgery - Cochrane for Clinicians...
Dec 1, 2009 - Routine preoperative testing before cataract surgery does not reduce intraoperative or postoperative complications.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2009/1201/p1228.html
Counseling Women About Mammography: Benefits vs. Harms - Cochrane for Clinicians - ...
Sep 1, 2007 - Studies of mammography show a 0.1 percent absolute reduction in breast cancer mortality with mammography. This means that if 2,000 women are offered mammography over 10 years, one woman would have her life prolonged, 10 healthy women would be treated unnecessarily for breast cancer, and...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2007/0901/p652.html
Fecal Occult Blood Tests Reduce Colorectal Cancer Mortality - Cochrane for Clinicians -...
Jun 1, 2007 - Fecal occult blood testing reduces colorectal cancer mortality by 16 percent. Annual testing and rehydration of samples increases testing sensitivity but also increases the number of false-positive results.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2007/0601/p1652.html
Screening for Prostate Cancer - Cochrane for Clinicians - American Family Physician
Feb 1, 2007 - There is insufficient evidence to determine whether screening for prostate cancer reduces mortality or impacts quality of life.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2007/0201/p336.html
What Is the Best Collection Device for Screening Cervical Smears? - Cochrane for ...
Apr 1, 2004 - The combination of an extended-tip spatula with an endocervical brush (Cytobrush) is the most effective method for obtaining cervical cells. Detection of endocervical cells is a good indication of adequate smears and detection of disease.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2004/0401/p1661.html
Should We Offer Routine Breast Cancer Screening with Mammography? - Cochrane for ...
Jul 15, 2003 - While there is good evidence that mammography starting at age 50 reduces breast cancer mortality, this meta-analysis does not provide evidence of a mortality benefit for mammography screening in women aged 40 to 49. Controversy exists over whether to include in the analysis trials with ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2003/0715/p260.html
navigate_before 1 navigate_next